Minds Navigating the Diagnosis of Mild Cognitive Impairment

The goal of this clinical trial is to find out if a 9 week group therapy using video from home will help veterans with Mild Cognitive Impairment (MCI). The main questions it aims to answer are:is the video therapy user-friendly for veterans?does it improve veterans well-being and quality-of-life?Veterans will be asked to attend nine 1 hour small group video sessions and will complete questionnaires before and after the sessions.Researchers will compare the group of veterans that starts the video sessions right away with a group that waits before starting the video sessions.

Inclusion Criteria:Veteranage 60 or olderdiagnosis of MCI, diagnosed at least a month or longer prior to screeningdiagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity)self-reported cognitive complaint (i.e., "Do you have problems with your memory or thinking abilities?")self-reported difficulty adjusting to declines in cognitive functioning (i.e., "Have these problems with memory or thinking impacted you, your life, or others in your life?")English speaking, and (h) ability to provide written informed consentExclusion Criteria:diagnosis of dementia or a neurodegenerative disorderdiagnosis of serious mental illness likely to impact cognition (i.e., schizophrenia or bipolar I disorder)acutely suicidal or homicidalactively psychoticactive substance use disorderlimited life expectancy due to a terminal medical conditionreceiving ongoing chemotherapy or radiation treatment at time of screeningresiding in an assisted living or residential care facilitycurrently participating in another psychotherapy, health promotion intervention, or cognitive training program, andany significant changes to psychotropic medications or medications for memory and cognition in the past month. Participants prescribed psychotropic medications and medications for memory and cognition will be asked to stay on their current dosages for the duration of the study.